Suppr超能文献

[长期抗惊厥治疗中γ-谷氨酰转移酶、天冬氨酸氨基转移酶、丙氨酸氨基转移酶和碱性磷酸酶血清活性的改变——苯妥英钠与卡马西平的比较]

[Altered gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase serum activities in long-term anticonvulsive therapy--comparison of diphenylhydantoin and carbamazepine].

作者信息

Aldenhövel H G

机构信息

Neurologische Abteilung, Akademisches Lehrkrankenhaus, Universität Bonn, Bundesrepublik Deutschland.

出版信息

Wien Klin Wochenschr. 1988 Oct 21;100(20):680-3.

PMID:2907210
Abstract

In 110 patients receiving a long-term anticonvulsant monotherapy with Diphenylhydantoin (DPH) and Carbamazepine (CBZ) the serum activities of gamma-GT, ASAT, ALAT, and AP were examined retrospectively. Elevated serum levels of enzymes were seen predominantly concerning gamma-GT and AP. 91% resp. 39% of patients receiving DPH-therapy showed increased gamma-GT resp. AP-levels compared to 64% and 14% of gamma-GT and AP-elevations by CBZ-treatment. All enzymes evaluated were more often and higher elevated by DPH than CBZ. Frequency and extent of increased activity of gamma-GT were highly related to daily dosage in both preparations. The proportion of pathological enzyme levels was associated with age in DPH and CBZ as well but not found to be significant. Sex differences in the frequency of increased enzyme activities could not be demonstrated. The results are discussed in the context of induction of cytochrome P-450-system.

摘要

对110例接受苯妥英(DPH)和卡马西平(CBZ)长期抗惊厥单药治疗的患者,回顾性检测了γ-GT、谷草转氨酶(ASAT)、谷丙转氨酶(ALAT)和碱性磷酸酶(AP)的血清活性。酶的血清水平升高主要与γ-GT和AP有关。接受DPH治疗的患者中,分别有91%和39%的患者γ-GT和AP水平升高,而接受CBZ治疗的患者中,γ-GT和AP升高的比例分别为64%和14%。与CBZ相比,DPH使所有评估的酶升高的频率更高、幅度更大。两种制剂中,γ-GT活性增加的频率和程度均与日剂量高度相关。病理酶水平的比例在DPH和CBZ中也与年龄有关,但未发现具有显著性。未证实酶活性增加频率存在性别差异。结合细胞色素P-450系统的诱导情况对结果进行了讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验